Nosocomial fungal infections: epidemiology, infection control, and prevention.

[1]  D. Horn,et al.  Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008. , 2012, Diagnostic microbiology and infectious disease.

[2]  S. Magill,et al.  Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  Claudio Viscoli,et al.  Occurrence, presentation and treatment of candidemia , 2012, Expert review of clinical immunology.

[4]  S. Parija,et al.  Candida parapsilosis: an emerging fungal pathogen , 2012, The Indian journal of medical research.

[5]  D. Horn,et al.  The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. , 2012, Diagnostic microbiology and infectious disease.

[6]  D. McKenna,et al.  Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability. , 2012, The American journal of medicine.

[7]  C. Clancy,et al.  Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  S. Han,et al.  Impact of First-Line Antifungal Agents on the Outcomes and Costs of Candidemia , 2012, Antimicrobial Agents and Chemotherapy.

[9]  C. Glen Mayhall,et al.  Hospital Epidemiology and Infection Control , 2011 .

[10]  P. Vanhems,et al.  Aspergillosis: nosocomial or community-acquired? , 2011, Medical mycology.

[11]  J. Sobel,et al.  Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit , 2011, Mycoses.

[12]  Sanjay Saint,et al.  Guidelines for the prevention of intravascular catheter-related infections. , 2002, American journal of infection control.

[13]  A. Rodloff,et al.  Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion , 2010, Journal of Clinical Microbiology.

[14]  R. Weber,et al.  Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients , 2010, Transplant infectious disease : an official journal of the Transplantation Society.

[15]  Jordi Rello,et al.  International study of the prevalence and outcomes of infection in intensive care units. , 2009, JAMA.

[16]  Nina Singh,et al.  Invasive Aspergillosis in Solid Organ Transplant Recipients , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  W. Meyer,et al.  Molecular Epidemiology of Invasive Aspergillosis: Lessons Learned from an Outbreak Investigation in an Australian Hematology Unit , 2009, Infection Control & Hospital Epidemiology.

[18]  Russell E. Lewis,et al.  Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001‐2007) , 2009, Cancer.

[19]  Hermann Einsele,et al.  Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective , 2009, Biology of Blood and Marrow Transplantation.

[20]  H. Yazaki,et al.  Outbreak of Pneumocystis jiroveci Pneumonia in Renal Transplant Recipients: P. jiroveci Is Contagious to the Susceptible Host , 2009, Transplantation.

[21]  V. Cheng,et al.  Outbreak of Intestinal Infection Due to Rhizopus microsporus , 2009, Journal of Clinical Microbiology.

[22]  M. Arduino,et al.  Contaminated Product Water as the Source of Phialemonium curvatum Bloodstream Infection among Patients Undergoing Hemodialysis , 2009, Infection Control & Hospital Epidemiology.

[23]  P. Hsueh,et al.  Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  E. Anaissie,et al.  Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  E. Manavathu,et al.  Aspergillus flavus: an emerging non‐fumigatus Aspergillus species of significance , 2009, Mycoses.

[26]  L. Romani,et al.  Invasive aspergillosis in chronic granulomatous disease. , 2009, Medical mycology.

[27]  J. Sobel,et al.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  E. Anaissie,et al.  Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  K. Ho,et al.  Candida rugosa: a distinctive emerging cause of candidaemia. A case report and review of the literature , 2009, Scandinavian journal of infectious diseases.

[30]  A. Antoniadou.  Outbreaks of zygomycosis in hospitals. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[31]  J. Guarro,et al.  Sequence-Based Identification of Aspergillus, Fusarium, and Mucorales Species in the Clinical Mycology Laboratory: Where Are We and Where Should We Go from Here? , 2008, Journal of Clinical Microbiology.

[32]  W. Popp,et al.  Environmental sampling of particulate matter and fungal spores during demolition of a building on a hospital area. , 2008, The Journal of hospital infection.

[33]  E. Bouza,et al.  Epidemiology of candidemia in intensive care units. , 2008, International journal of antimicrobial agents.

[34]  A. Hidrón,et al.  Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007 , 2008, Infection Control & Hospital Epidemiology.

[35]  S. Saint,et al.  Strategies to Prevent Central Line–Associated Bloodstream Infections in Acute Care Hospitals , 2008, Infection Control & Hospital Epidemiology.

[36]  K. Machin,et al.  Investigation and management of an outbreak of mucormycosis in a paediatric oncology unit. , 2008, The Journal of hospital infection.

[37]  M. Kollef,et al.  Secular Trends in Candidemia-Related Hospitalization in the United States, 2000–2005 , 2008, Infection Control & Hospital Epidemiology.

[38]  G. Slotman,et al.  Empirical Fluconazole versus Placebo for Intensive Care Unit Patients , 2008, Annals of Internal Medicine.

[39]  Jianping Xu,et al.  Molecular epidemiology of candidemia: evidence of clusters of smoldering nosocomial infections. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  D. Marriott,et al.  Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp. , 2008, Critical care medicine.

[41]  D. Kontoyiannis,et al.  The changing epidemiology of invasive candidiasis , 2008, Cancer.

[42]  K. L. Mathews,et al.  Effect of Building Construction on Aspergillus Concentrations in a Hospital , 2008, Infection Control & Hospital Epidemiology.

[43]  W. Hop,et al.  Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  Raoul Herbrecht,et al.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  J. Heesemann,et al.  Molecular Evidence of Nosocomial Pneumocystis jirovecii Transmission among 16 Patients after Kidney Transplantation , 2008, Journal of Clinical Microbiology.

[46]  M. Pfaller,et al.  Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing , 2007, Journal of Clinical Microbiology.

[47]  Thomas R Rogers,et al.  Treatment of zygomycosis: current and new options. , 2008, The Journal of antimicrobial chemotherapy.

[48]  R. Barton,et al.  Candida krusei, a Multidrug-Resistant Opportunistic Fungal Pathogen: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005 , 2007, Journal of Clinical Microbiology.

[49]  F. Dalle,et al.  Prospective survey of indoor fungal contamination in hospital during a period of building construction. , 2007, The Journal of hospital infection.

[50]  K. Marr,et al.  Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients , 2007, British journal of haematology.

[51]  William E Trick,et al.  Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. , 2007, Archives of internal medicine.

[52]  D. Stevens,et al.  Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source, and review of published studies , 2007, Mycopathologia.

[53]  K. Laupland,et al.  Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. , 2007, The Journal of antimicrobial chemotherapy.

[54]  W. Meersseman,et al.  Invasive aspergillosis in the ICU: an emerging disease , 2007, Intensive Care Medicine.

[55]  E. van Wijngaerden,et al.  Invasive aspergillosis in the intensive care unit. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[56]  V. Anttila,et al.  The utility of intensified environmental surveillance for pathogenic moulds in a stem cell transplantation ward during construction work to monitor the efficacy of HEPA filtration , 2007, Bone Marrow Transplantation.

[57]  T. Wong,et al.  Risk factors for contact lens-related fusarium keratitis: a case-control study in Singapore. , 2007, Archives of ophthalmology.

[58]  H. V. van Houwelingen,et al.  An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source? , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[59]  W. Hughes.  Transmission of Pneumocystis species among renal transplant recipients. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[60]  J. Meis,et al.  Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2005: an 8.5-Year Analysis of Susceptibilities of Candida Species and Other Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing , 2007, Journal of Clinical Microbiology.

[61]  J. Guinea,et al.  Impact of Zygomycosis on Microbiology Workload: a Survey Study in Spain , 2007, Journal of Clinical Microbiology.

[62]  P. Smith,et al.  Excess Costs of Hospital Care Associated With Neonatal Candidemia , 2007, The Pediatric infectious disease journal.

[63]  B. Alexander,et al.  Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[64]  M. Boeckh,et al.  Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[65]  F. Dalle,et al.  Reduced fungal contamination of the indoor environment with the Plasmair system (Airinspace). , 2007, Journal of Hospital Infection.

[66]  J. Lipton,et al.  Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. , 2007, The New England journal of medicine.

[67]  M. Pfaller,et al.  Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem , 2007, Clinical Microbiology Reviews.

[68]  P. Pronovost,et al.  An intervention to decrease catheter-related bloodstream infections in the ICU. , 2006, The New England journal of medicine.

[69]  M. Arduino,et al.  Outbreak of cutaneous Rhizopus arrhizus infection associated with karaya ostomy bags. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[70]  M. Arduino,et al.  Outbreak of Bloodstream Infection With the Mold Phialemonium Among Patients Receiving Dialysis at a Hemodialysis Unit , 2006, Infection Control & Hospital Epidemiology.

[71]  E. Leray,et al.  Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[72]  K. Wannemuehler,et al.  Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. , 2006, JAMA.

[73]  A. Webster,et al.  Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients , 2006, European Journal of Clinical Microbiology and Infectious Diseases.

[74]  P. Gastmeier,et al.  Nosocomial aspergillosis in outbreak settings. , 2006, The Journal of hospital infection.

[75]  M. Falagas,et al.  Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies , 2006, European Journal of Clinical Microbiology and Infectious Diseases.

[76]  M. Cuenca‐Estrella,et al.  Epidemiology, Risk Factors, and Prognosis of Candida parapsilosis Bloodstream Infections: Case-Control Population-Based Surveillance Study of Patients in Barcelona, Spain, from 2002 to 2003 , 2006, Journal of Clinical Microbiology.

[77]  J. Garnacho-Montero,et al.  A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization* , 2006, Critical care medicine.

[78]  S. Holland,et al.  Immunotherapy for fungal infections. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[79]  D. Maki,et al.  Disinfection of Needleless Catheter Connectors and Access Ports With Alcohol May Not Prevent Microbial Entry: The Promise of a Novel Antiseptic-Barrier Cap , 2006, Infection Control & Hospital Epidemiology.

[80]  S. Fridkin.  The changing face of fungal infections in health care settings. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[81]  Michael Y. Lin,et al.  Prior Antimicrobial Therapy and Risk for Hospital-Acquired Candida glabrata and Candida krusei Fungemia: a Case-Case-Control Study , 2005, Antimicrobial Agents and Chemotherapy.

[82]  J. Berlin,et al.  The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[83]  C. Kauffman,et al.  Candida glabrata fungemia: experience in a tertiary care center. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[84]  D. Kontoyiannis,et al.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[85]  P. de Mol,et al.  An outbreak of Absidia corymbifera infection associated with bandage contamination in a burns unit. , 2005, The Journal of hospital infection.

[86]  Edward Horowitz,et al.  HOSPITAL EPIDEMIOLOGY AND INFECTION CONTROL, 3RD EDITION , 2005 .

[87]  M. Arduino,et al.  Saline-filled breast implant contamination with Curvularia species among women who underwent cosmetic breast augmentation. , 2005, The Journal of infectious diseases.

[88]  S. Teutsch,et al.  Excess Mortality, Hospital Stay, and Cost Due to Candidemia: A Case-Control Study Using Data From Population-Based Candidemia Surveillance , 2005, Infection Control & Hospital Epidemiology.

[89]  S. Fridkin,et al.  Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003 , 2005, Journal of Clinical Microbiology.

[90]  L. Pagano,et al.  Invasive Infections Caused by Trichosporon Species and Geotrichum capitatum in Patients with Hematological Malignancies: a Retrospective Multicenter Study from Italy and Review of the Literature , 2005, Journal of Clinical Microbiology.

[91]  G. Rahav,et al.  An outbreak of Phialemonium infective endocarditis linked to intracavernous penile injections for the treatment of impotence. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[92]  J. Garnacho-Montero,et al.  Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome , 2005, Critical care.

[93]  M. Bértoli,et al.  High frequency of Candida parapsilosis on the hands of healthy hosts. , 2005, The Journal of hospital infection.

[94]  P. Hauser,et al.  Molecular Evidence of Pneumocystis Transmission in Pediatric Transplant Unit , 2005, Emerging infectious diseases.

[95]  N. Singh.  Invasive aspergillosis in organ transplant recipients: new issues in epidemiologic characteristics, diagnosis, and management. , 2005, Medical mycology.

[96]  Y. Shan,et al.  Early Presumptive Therapy with Fluconazole for Occult Candida Infection after Gastrointestinal Surgery , 2005, World Journal of Surgery.

[97]  J. Lipton,et al.  Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[98]  J. Robinson,et al.  Genetic Diversity of Human Pathogenic Members of the Fusarium oxysporum Complex Inferred from Multilocus DNA Sequence Data and Amplified Fragment Length Polymorphism Analyses: Evidence for the Recent Dispersion of a Geographically Widespread Clonal Lineage and Nosocomial Origin , 2004, Journal of Clinical Microbiology.

[99]  R. Prasad,et al.  Epidemiology and molecular typing of Candida isolates from burn patients , 2004, Mycopathologia.

[100]  Peter J Pronovost,et al.  Eliminating catheter-related bloodstream infections in the intensive care unit* , 2004, Critical care medicine.

[101]  S. Fridkin,et al.  Epidemiologic and Molecular Characterization of an Outbreak of Candida parapsilosis Bloodstream Infections in a Community Hospital , 2004, Journal of Clinical Microbiology.

[102]  P. Vanhems,et al.  Molecular Evidence of Interhuman Transmission of Pneumocystis Pneumonia among Renal Transplant Recipients Hospitalized with HIV-Infected Patients , 2004, Emerging infectious diseases.

[103]  D. Denning.  Aspergillosis in "nonimmunocompromised" critically ill patients. , 2004, American journal of respiratory and critical care medicine.

[104]  A. Wilmer,et al.  Invasive aspergillosis in critically ill patients without malignancy. , 2004, American journal of respiratory and critical care medicine.

[105]  R. Wenzel,et al.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[106]  D. Kontoyiannis,et al.  Trichosporonosis in a tertiary care cancer center: Risk factors, changing spectrum and determinants of outcome , 2004, Scandinavian journal of infectious diseases.

[107]  R. Summerbell,et al.  Phialemonium: an emerging mold pathogen that caused 4 cases of hemodialysis-associated endovascular infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[108]  M. Ghannoum,et al.  Candida parapsilosis Characterization in an Outbreak Setting , 2004, Emerging infectious diseases.

[109]  A. Tortorano,et al.  Candidosis in the intensive care unit: a 20-year survey. , 2004, The Journal of hospital infection.

[110]  E. Anaissie,et al.  Fusarium infection in hematopoietic stem cell transplant recipients. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[111]  Lee H. Harrison,et al.  Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program , 2004, Journal of Clinical Microbiology.

[112]  A. Tarkkanen,et al.  Fungal endophthalmitis caused by Paecilomyces variotii following cataract surgery: a presumed operating room air-conditioning system contamination. , 2004, Acta ophthalmologica Scandinavica.

[113]  F. Colardyn,et al.  Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence. , 2004, The Journal of hospital infection.

[114]  D. Pittet,et al.  Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[115]  M. Ghannoum,et al.  Candida biofilms: antifungal resistance and emerging therapeutic options. , 2004, Current opinion in investigational drugs.

[116]  J. Sobel,et al.  Guidelines for treatment of candidiasis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[117]  C. Bridges,et al.  Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. , 2004, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[118]  Acip.  Prevention and control of influenza : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2004 .

[119]  S. Heinemanna,et al.  Environmental investigations and molecular typing of Aspergillus flavus during an outbreak of postoperative infections , 2004 .

[120]  E. Mellado,et al.  Outbreak of gastric mucormycosis associated with the use of wooden tongue depressors in critically ill patients , 2004, Intensive Care Medicine.

[121]  R. Luzzati,et al.  Nosocomial Cluster of Candida guillermondii Fungemia in Surgical Patients , 2003, European Journal of Clinical Microbiology and Infectious Diseases.

[122]  W. Powderly,et al.  A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[123]  R. Salomão,et al.  Outbreak of Candida rugosa candidemia: an emerging pathogen that may be refractory to amphotericin B therapy. , 2003, Diagnostic microbiology and infectious disease.

[124]  L. Sehulster,et al.  Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[125]  M. Territo,et al.  Intravenous and Oral Itraconazole versus Intravenous and Oral Fluconazole for Long-Term Antifungal Prophylaxis in Allogeneic Hematopoietic Stem-Cell Transplant Recipients: A Multicenter, Randomized Trial , 2003, Annals of Internal Medicine.

[126]  John H Rex,et al.  Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies. , 2003, Blood.

[127]  P. Francioli,et al.  Risk for Pneumocystis carinii Transmission among Patients with Pneumonia: a Molecular Epidemiology Study , 2003, Emerging infectious diseases.

[128]  Nina Singh,et al.  Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[129]  M. Boeckh,et al.  Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. , 2002, Blood.

[130]  F. Gritti,et al.  Invasive Aspergillosis in Italian AIDS Patients , 2002, Infection.

[131]  Didier Pittet,et al.  Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. , 2002, American journal of infection control.

[132]  Didier Pittet,et al.  Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Dis , 2002, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[133]  J. Duchin,et al.  The role of person-to-person transmission in an epidemiologic study of Pneumocystis carinii pneumonia , 2002, AIDS.

[134]  R. Gaynes,et al.  Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[135]  R. D. McCormick,et al.  Guidelines for the Prevention of Intravascular Catheter–Related Infections , 2002, Infection Control & Hospital Epidemiology.

[136]  E. Ghelardi,et al.  Horizontal Transmission of Candida parapsilosis Candidemia in a Neonatal Intensive Care Unit , 2002, Journal of Clinical Microbiology.

[137]  Robert F Miller,et al.  Probable Mother-to-Infant Transmission of Pneumocystis carinii f. sp. hominis Infection , 2002, Journal of Clinical Microbiology.

[138]  Lawrence Corey,et al.  Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[139]  E. Anaissie,et al.  Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[140]  M. Ghannoum,et al.  Comparison of Biofilms Formed by Candidaalbicans and Candidaparapsilosis on Bioprosthetic Surfaces , 2002, Infection and Immunity.

[141]  W. Hope,et al.  Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use. , 2002, The Journal of hospital infection.

[142]  J. Wingard,et al.  Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital , 2002, Bone Marrow Transplantation.

[143]  J. Beney,et al.  The direct cost and incidence of systemic fungal infections. , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[144]  E. Anaissie,et al.  Revisiting the source of candidemia: skin or gut? , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[145]  L. Saiman,et al.  Risk factors for Candida species colonization of neonatal intensive care unit patients. , 2001, The Pediatric infectious disease journal.

[146]  D. Wolf,et al.  Multidrug-Resistant Trichosporon asahii Infection of Nongranulocytopenic Patients in Three Intensive Care Units , 2001, Journal of Clinical Microbiology.

[147]  S. Chanock,et al.  Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[148]  J. Thornby,et al.  Risk Factors for Candida tropicalis fungemia in patients with cancer. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[149]  R. Hajjeh,et al.  Counterpoint: invasive aspergillosis and the environment--rethinking our approach to prevention. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[150]  E. Anaissie,et al.  Nosocomial aspergillosis is waterborne. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[151]  L. Saiman,et al.  Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[152]  E. Daar,et al.  The Epidemiology of Invasive Pulmonary Aspergillosis at a Large Teaching Hospital , 2001, Infection Control & Hospital Epidemiology.

[153]  J. Rodríguez-Tudela,et al.  Airborne outbreak of nosocomial Scedosporium prolificans infection , 2001, The Lancet.

[154]  C. Payá,et al.  Fusarium infection after solid-organ transplantation. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[155]  B. Petrini,et al.  Malassezia pachydermatis fungaemia in a neonatal intensive care unit , 2001, Acta paediatrica.

[156]  G. Mcleod,et al.  Candida osteomyelitis and diskitis after spinal surgery: an outbreak that implicates artificial nail use. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[157]  S. Fanello,et al.  Nosocomial Candida albicans acquisition in a geriatric unit: epidemiology and evidence for person-to-person transmission. , 2001, The Journal of hospital infection.

[158]  S. Teutsch,et al.  Burden of aspergillosis-related hospitalizations in the United States. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[159]  K. Marr.  The changing spectrum of candidemia in oncology patients: therapeutic implications , 2000, Current opinion in infectious diseases.

[160]  G. Bodey,et al.  Candida krusei fungemia. An escalating serious infection in immunocompromised patients. , 2000, Archives of internal medicine.

[161]  M. Cawley,et al.  Trichosporon beigelii infection: experience in a regional burn center. , 2000, Burns : journal of the International Society for Burn Injuries.

[162]  V. Yu,et al.  Prophylactic fluconazole in liver transplant recipients. , 2000, Annals of internal medicine.

[163]  R. Patel.  Prophylactic fluconazole in liver transplant recipients: A randomized, double‐blind, placebo‐controlled trial , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[164]  Sergio L Vargas,et al.  Transmission of Pneumocystis carinii DNA from a Patient with P. carinii Pneumonia to Immunocompetent Contact Health Care Workers , 2000, Journal of Clinical Microbiology.

[165]  L. Saiman,et al.  Risk factors for candidemia in Neonatal Intensive Care Unit patients , 2000, The Pediatric infectious disease journal.

[166]  M. Richardson,et al.  Sampling of Aspergillus spores in air. , 2000, The Journal of hospital infection.

[167]  D. Denning,et al.  Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: a European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the Intergroupe Français du Myélome. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[168]  R. Pinner,et al.  The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[169]  L. Saiman,et al.  National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[170]  P. Francioli,et al.  Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. , 1999, Critical care medicine.

[171]  A. van Belkum,et al.  Density and Molecular Epidemiology ofAspergillus in Air and Relationship to Outbreaks ofAspergillus Infection , 1999, Journal of Clinical Microbiology.

[172]  J. Cornish,et al.  Infections in adults undergoing unrelated donor bone marrow transplantation , 1999, British journal of haematology.

[173]  Nina Singh,et al.  Invasive aspergillosis in transplant recipients. , 1999, Medicine.

[174]  S. Špánik,et al.  Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol , 1999, Supportive Care in Cancer.

[175]  R. Pinner,et al.  The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[176]  C. Leutner,et al.  Changing role of invasive aspergillosis in AIDS--a case control study. , 1998, Journal of Infection.

[177]  R Sylvester,et al.  An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. , 1998, The Journal of infection.

[178]  P. Kvale,et al.  Risk Factors and Outcomes Associated With Identification of Aspergillus in Respiratory Specimens From Persons With HIV Disease , 1998 .

[179]  L. Rubin,et al.  Emergence of Candida parapsilosis as the predominant species causing candidemia in children. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[180]  D. Geiger,et al.  Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheters and the hands of healthcare workers. , 1998, Diagnostic microbiology and infectious disease.

[181]  D. Ashford,et al.  An epidemic of Malassezia pachydermatis in an intensive care nursery associated with colonization of health care workers' pet dogs. , 1998, The New England journal of medicine.

[182]  J. Sobel,et al.  Nosocomial Candida glabrata Colonization: an Epidemiologic Study , 1998, Journal of Clinical Microbiology.

[183]  P. Kvale,et al.  Risk factors and outcomes associated with identification of Aspergillus in respiratory specimens from persons with HIV disease. Pulmonary Complications of HIV Infection Study Group. , 1998, Chest.

[184]  J. Martínez-Suárez,et al.  Use of Random Amplification of Polymorphic DNA (RAPD) and PCR-Fingerprinting for Genotyping a Scedosporium prolificans (inflatum) Outbreak in Four Leukemic Patients , 1997, Current Microbiology.

[185]  J. Latgé,et al.  Genetic diversity among clinical and environmental isolates of Aspergillus fumigatus , 1997, Infection and immunity.

[186]  E. Anaissie,et al.  The epidemiology of hematogenous candidiasis caused by different Candida species. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[187]  T. Patterson,et al.  Hospital Epidemiologic Surveillance for Invasive Aspergillosis: Patient Demographics and the Utility of Antigen Detection , 1997, Infection Control & Hospital Epidemiology.

[188]  P. Itin,et al.  Outbreak of Invasive Mycoses Caused by Paecilomyces lilacinus from a Contaminated Skin Lotion , 1996, Annals of Internal Medicine.

[189]  D. Dunn,et al.  Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome. , 1996, Journal of the American College of Surgeons.

[190]  M. Hocking,et al.  Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors , 1996, The Lancet.

[191]  A. Delmer,et al.  Two cases of epidemic mucormycosis infection in patients with acute lymphoblastic leukemia , 1996, American journal of hematology.

[192]  M. Pfaller.  Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[193]  E. Bryce,et al.  An Outbreak of Cutaneous Aspergillosis in a Tertiary-Care Hospital , 1996, Infection Control & Hospital Epidemiology.

[194]  A. van Belkum,et al.  Molecular epidemiology of apparent outbreak of invasive aspergillosis in a hematology ward , 1996, Journal of clinical microbiology.

[195]  J. Martínez-Suárez,et al.  Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients , 1995, Journal of clinical microbiology.

[196]  J. Dupouy-Camet,et al.  Use of random amplified polymorphic DNA as a typing method for Candida albicans in epidemiological surveillance of a burn unit , 1995, Journal of clinical microbiology.

[197]  M. Levenstein,et al.  Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. , 1995, The Journal of infectious diseases.

[198]  M. Wallace,et al.  Invasive aspergillosis in patients with AIDS. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[199]  D. Armstrong,et al.  Catheter-related Malassezia furfur fungemia in immunocompromised patients. , 1993, The American journal of medicine.

[200]  J. Sobel,et al.  Nosocomial acquisition of Candida albicans: an epidemiologic study. , 1993, The Journal of infectious diseases.

[201]  L. Odom,et al.  Heliport-associated nosocomial mucormycoses. , 1992, Infection control and hospital epidemiology.

[202]  J. L. Goodman,et al.  A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. , 1992, The New England journal of medicine.

[203]  T. Barlam,et al.  Invasive aspergillosis in patients with AIDS. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[204]  B. Fox,et al.  Heavy contamination of operating room air by Penicillium species: identification of the source and attempts at decontamination. , 1990, American journal of infection control.

[205]  H. Richet,et al.  Cluster of Malassezia furfur pulmonary infections in infants in a neonatal intensive-care unit , 1989, Journal of clinical microbiology.

[206]  A. Gratwohl,et al.  Bottled lemon juice--a cryptic source of invasive Candida infections in the immunocompromised host. , 1988, The Journal of infectious diseases.

[207]  R. Jones,et al.  Outbreak of primary cutaneous aspergillosis related to intravenous arm boards. , 1986, The Journal of pediatrics.